BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 26984608)

  • 1. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
    Sedel F; Chabrol B; Audoin B; Kaphan E; Tranchant C; Burzykowski T; Tourbah A; Vanier MT; Galanaud D
    J Neurol; 2016 May; 263(5):927-936. PubMed ID: 26984608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study.
    Patterson MC; Mengel E; Vanier MT; Schwierin B; Muller A; Cornelisse P; Pineda M;
    Orphanet J Rare Dis; 2015 May; 10():65. PubMed ID: 26017010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initiation and discontinuation of substrate inhibitor treatment in patients with Niemann-Pick type C disease.
    Pérez-Poyato MS; Gordo MM; Marfa MP
    Gene; 2012 Sep; 506(1):207-10. PubMed ID: 22750297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
    Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
    Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy.
    Galanaud D; Tourbah A; Lehéricy S; Leveque N; Heron B; Billette de Villemeur T; Guffon N; Feillet F; Baumann N; Vanier MT; Sedel F
    Mol Genet Metab; 2009 Feb; 96(2):55-8. PubMed ID: 19013089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
    Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
    Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Miglustat in Niemann-Pick disease type C patients: a review.
    Pineda M; Walterfang M; Patterson MC
    Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Miglustat in patients with Niemann-Pick disease Type C (NP-C): a multicenter observational retrospective cohort study.
    Pineda M; Wraith JE; Mengel E; Sedel F; Hwu WL; Rohrbach M; Bembi B; Walterfang M; Korenke GC; Marquardt T; Luzy C; Giorgino R; Patterson MC
    Mol Genet Metab; 2009 Nov; 98(3):243-9. PubMed ID: 19656703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early miglustat therapy in infantile Niemann-Pick disease type C.
    Di Rocco M; Dardis A; Madeo A; Barone R; Fiumara A
    Pediatr Neurol; 2012 Jul; 47(1):40-3. PubMed ID: 22704015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.
    Héron B; Valayannopoulos V; Baruteau J; Chabrol B; Ogier H; Latour P; Dobbelaere D; Eyer D; Labarthe F; Maurey H; Cuisset JM; de Villemeur TB; Sedel F; Vanier MT
    Orphanet J Rare Dis; 2012 Jun; 7():36. PubMed ID: 22676771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term miglustat therapy in children with Niemann-Pick disease type C.
    Patterson MC; Vecchio D; Jacklin E; Abel L; Chadha-Boreham H; Luzy C; Giorgino R; Wraith JE
    J Child Neurol; 2010 Mar; 25(3):300-5. PubMed ID: 19822772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
    Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
    Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series.
    Pineda M; Perez-Poyato MS; O'Callaghan M; Vilaseca MA; Pocovi M; Domingo R; Portal LR; Pérez AV; Temudo T; Gaspar A; Peñas JJ; Roldán S; Fumero LM; de la Barca OB; Silva MT; Macías-Vidal J; Coll MJ
    Mol Genet Metab; 2010 Apr; 99(4):358-66. PubMed ID: 20056559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial.
    Wraith JE; Vecchio D; Jacklin E; Abel L; Chadha-Boreham H; Luzy C; Giorgino R; Patterson MC
    Mol Genet Metab; 2010 Apr; 99(4):351-7. PubMed ID: 20045366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year.
    Chien YH; Lee NC; Tsai LK; Huang AC; Peng SF; Chen SJ; Hwu WL
    J Inherit Metab Dis; 2007 Oct; 30(5):826. PubMed ID: 17603755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry.
    Patterson MC; Mengel E; Vanier MT; Moneuse P; Rosenberg D; Pineda M
    Orphanet J Rare Dis; 2020 Apr; 15(1):104. PubMed ID: 32334605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study.
    Patterson MC; Vecchio D; Prady H; Abel L; Wraith JE
    Lancet Neurol; 2007 Sep; 6(9):765-72. PubMed ID: 17689147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
    Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
    JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.
    Santos ML; Raskin S; Telles DS; Löhr A; Liberalesso PB; Vieira SC; Cordeiro ML
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S357-61. PubMed ID: 18937049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.